Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis.

Literature DB >> 7787647

Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis.

D S Armstrong¹, K Grimwood, R Carzino, J B Carlin, A Olinsky, P D Phelan.

Abstract

Entities: Disease Species

Mesh：

Year: 1995 PMID： 7787647 PMCID： PMC2549944 DOI： 10.1136/bmj.310.6994.1571

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

5 in total

1. Diagnosing bacterial respiratory infection by bronchoalveolar lavage.

Authors: F W Kahn; J M Jones
Journal: J Infect Dis Date: 1987-05 Impact factor: 5.226

2. Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening.

Authors: S H Abman; J W Ogle; R J Harbeck; N Butler-Simon; K B Hammond; F J Accurso
Journal: J Pediatr Date: 1991-08 Impact factor: 4.406

3. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

Authors: M W Konstan; K A Hilliard; T M Norvell; M Berger
Journal: Am J Respir Crit Care Med Date: 1994-08 Impact factor: 21.405

4. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients.

Authors: B W Ramsey; K R Wentz; A L Smith; M Richardson; J Williams-Warren; D L Hedges; R Gibson; G J Redding; K Lent; K Harris
Journal: Am Rev Respir Dis Date: 1991-08

5. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.

Authors: P Birrer; N G McElvaney; A Rüdeberg; C W Sommer; S Liechti-Gallati; R Kraemer; R Hubbard; R G Crystal
Journal: Am J Respir Crit Care Med Date: 1994-07 Impact factor: 21.405

5 in total

78 in total

Review 1. Cystic fibrosis.

Authors: P Robinson
Journal: Thorax Date: 2001-03 Impact factor: 9.139

Review 2. Physiotherapy in cystic fibrosis.

Authors: S A Prasad; E L Tannenbaum; C Mikelsons
Journal: J R Soc Med Date: 2000 Impact factor: 5.344

3. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation.

Authors: Torsten H Schroeder; Martin M Lee; Patrick W Yacono; Carolyn L Cannon; A Alev Gerçeker; David E Golan; Gerald B Pier
Journal: Proc Natl Acad Sci U S A Date: 2002-05-07 Impact factor: 11.205

Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis.

1. Diagnosing bacterial respiratory infection by bronchoalveolar lavage.

2. Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening.

3. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

4. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients.

5. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.

Review 1. Cystic fibrosis.

Review 2. Physiotherapy in cystic fibrosis.

3. CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa LPS from the outer membrane into epithelial cells and activates NF-kappa B translocation.

Review 4. New therapeutic approaches for cystic fibrosis lung disease.

Review 5. Spectrum of viral infections in patients with cystic fibrosis.

6. Risk of hemoptysis in cystic fibrosis clinical trials: A retrospective cohort study.

Review 7. Monitoring inflammation in CF. Cytokines.

Review 8. The role of inflammation in the pathophysiology of CF lung disease.

9. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.

10. Early airway infection, inflammation, and lung function in cystic fibrosis.